{"id":"NCT01255787","sponsor":"Takeda","briefTitle":"Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder","officialTitle":"A Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy and Safety of Lu AA21004 in Patients With Major Depressive Disorder","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-11","primaryCompletion":"2012-03","completion":"2012-04","firstPosted":"2010-12-07","resultsPosted":"2013-12-18","lastUpdate":"2013-12-18"},"enrollment":600,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Depressive Disorder, Major"],"interventions":[{"type":"DRUG","name":"Vortioxetine","otherNames":["Lu AA21004","Brintellix®"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"EXPERIMENTAL"},{"label":"Vortioxetine 5 mg","type":"EXPERIMENTAL"},{"label":"Vortioxetine 10 mg","type":"EXPERIMENTAL"},{"label":"Vortioxetine 20 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess the efficacy and safety of multiple doses of vortioxetine, once daily (QD), in participants with major depressive disorder.","primaryOutcome":{"measure":"Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score","timeFrame":"Baseline and Week 8","effectByArm":[{"arm":"Placebo","deltaMin":-13.99,"sd":0.783},{"arm":"Vortioxetine 5 mg","deltaMin":-14.61,"sd":0.805},{"arm":"Vortioxetine 10 mg","deltaMin":-15.68,"sd":0.791},{"arm":"Vortioxetine 20 mg","deltaMin":-15.82,"sd":0.786}],"pValues":[{"comp":"OG000 vs OG001","p":"0.9070"},{"comp":"OG000 vs OG002","p":"0.3006"},{"comp":"OG000 vs OG003","p":"0.2399"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":70,"countries":["Croatia","Finland","Germany","Hong Kong","India","Japan","Latvia","Malaysia","Philippines","Poland","Romania","Russia","Serbia","South Korea","Taiwan","Ukraine"]},"refs":{"pmids":["36708956","28858412"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":151},"commonTop":["Nausea","Nasopharyngitis","Headache","Diarrhoea","Dizziness"]}}